KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Total Debt (2019 - 2026)

GoodRx Holdings' Total Debt history spans 7 years, with the latest figure at $488.3 million for Q4 2025.

  • On a quarterly basis, Total Debt fell 0.7% to $488.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $488.3 million, a 0.7% decrease, with the full-year FY2025 number at $488.3 million, down 0.7% from a year prior.
  • Total Debt hit $488.3 million in Q4 2025 for GoodRx Holdings, roughly flat from $489.1 million in the prior quarter.
  • Over the last five years, Total Debt for GDRX hit a ceiling of $665.9 million in Q1 2021 and a floor of $488.3 million in Q4 2025.
  • Historically, Total Debt has averaged $608.7 million across 5 years, with a median of $656.6 million in 2023.
  • Biggest five-year swings in Total Debt: decreased 0.35% in 2023 and later fell 25.1% in 2024.
  • Tracing GDRX's Total Debt over 5 years: stood at $662.9 million in 2021, then decreased by 0.61% to $658.8 million in 2022, then dropped by 0.35% to $656.5 million in 2023, then fell by 25.1% to $491.7 million in 2024, then decreased by 0.7% to $488.3 million in 2025.
  • Business Quant data shows Total Debt for GDRX at $488.3 million in Q4 2025, $489.1 million in Q3 2025, and $490.0 million in Q2 2025.